Disparities in COVID-19 testing and outcomes among Asian American and Pacific Islanders: an observational study in a large health care system
Authors:
Open Access
- 6 February 2023
- journal article
- research article
- Published by Springer Nature in BMC Public Health
- Vol. 23 (1) , 1-14
Abstract
Background: The COVID-19 pandemic has disproportionately impacted racial and ethnic minorities in the United States, including Asian Americans, Native Hawaiians and Pacific Islanders (Asian Americans and NH/PIs). However, few studies have highlighted nor disaggregated these disparities by Asian Americans and NH/PIs ethnic subgroups. Methods: This retrospective, cross-sectional observational study aimed to assess variation of Asian Americans and NH/PIs COVID-19 testing and outcomes compared to non-Hispanic Whites (NHW). The study utilized data from the electronic health records (EHR) and the COVID-19 Universal Registry for Vital Evaluations (CURVE) from all patients tested for SARS-CoV-2 (n = 556,690) at a large, health system in Northern and Central California between February 20, 2020 and March 31, 2021. Chi-square tests were used for testing differences in the severity of COVID-19 (hospitalization, ICU admission, death) and patient demographic and clinical characteristics across the Asian Americans and NH/PIs subgroups and NHW. Unadjusted and adjusted Odds Ratios (ORs) were estimated for measuring effect of race ethnicity on severity of COVID-19 using multivariable logistic regression. Results: Of the entire tested population, 70,564/556,690 (12.7%) tested positive for SARS-CoV-2. SARS-CoV-2 positivity of Asian subgroups varied from 4% in the Chinese and Korean populations, to 11.2%, 13.5%, and 12.5% for Asian Indian, Filipino, and “other Asian” populations respectively. Pacific Islanders had the greatest subgroup test positivity at 20.1%. Among Asian Americans and NH/PIs patients with COVID-19 disease, Vietnamese (OR = 2.06, 95% CI = 1.30–3.25), “Other Asian” (OR = 2.13, 95% CI = 1.79–2.54), Filipino (OR = 1.78, 95% CI = 1.34–2.23), Japanese (OR = 1.78, 95% CI = 1.10–2.88), and Chinese (OR = 1.73, 95% CI = 1.34–2.23) subgroups had almost double the odds of hospitalization compared to NHW. Pacific Islander (OR = 1.58, 95% CI = 1.19–2.10) and mixed race subgroups (OR = 1.55, 95% CI = 1.10–2.20) had more than one and a half times odds of hospitalization compared to NHW. Adjusted odds of ICU admission or death among hospitalized patients by different Asian subgroups varied but were not statistically significant. Conclusions: Variation of COVID-19 testing and hospitalization by Asian subgroups was striking in our study. A focus on the Asian Americans and NH/PIs population with disaggregation of subgroups is crucial to understand nuances of health access, utilization, and outcomes among subgroups to create health equity for these underrepresented populations.Keywords
Funding Information
- Stanford University
This publication has 27 references indexed in Scilit:
- The association of race and COVID-19 mortalityeClinicalMedicine, 2020
- Disparities In Outcomes Among COVID-19 Patients In A Large Health Care System In CaliforniaHealth Affairs, 2020
- Public Health Response to the Initiation and Spread of Pandemic COVID-19 in the United States, February 24–April 21, 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- COVID-19 Special Column: COVID-19 Hits Native Hawaiian and Pacific Islander Communities the Hardest.2020
- The outbreak of COVID-19: An overviewJournal of the Chinese Medical Association, 2020
- [RETRACTED] Voices of Social Justice and Diversity in a Hawai‘i Context2019
- Does an immigrant health paradox exist among Asian Americans? Associations of nativity and occupational class with self-rated health and mental disordersSocial Science & Medicine, 2012
- Caught Between “The Rock” and a Hard Place: The Native Hawaiian and Pacific Islander Struggle for Identity in Public HealthAmerican Journal of Public Health, 2010
- Asian Americans’ reports of their health care experiencesJournal of General Internal Medicine, 2004
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987